Related Experiment Video
Updated: Sep 10, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
The Burden of Depression and Stigma Among Individuals With Tuberculosis Within the Integrated Tuberculosis-Mental
Ngozi Murphy-Okpala1, Charles Nwafor1, Chinwe Eze1
1Public Health, RedAid Nigeria, Enugu, NGA.
Abstract:
There is a complex bidirectional relationship between tuberculosis (TB), major depressive disorder (MDD), and stigma. Despite the significant burden of these conditions in sub-Saharan Africa, only a few studies have explored their interplay. The primary aim of this study is to determine the burden of MDD and the dimensions of stigma among individuals with TB. The secondary aim is to assess the effectiveness of integrated TB-depression treatment compared to standard TB treatment. This will be a multistage study utilizing a mixed-methods design to address the research questions. Stage 1 will use a cross-sectional design to evaluate the burden of depression and stigma. Depression will be assessed using the Patient Health Questionnaire-9 (PHQ-9), and stigma will be measured using Van Rie's TB stigma scales - covering self-stigma, secondary stigma, community stigma, and stigma among healthcare workers. Stage 2 will involve a longitudinal follow-up of all eligible participants diagnosed with both TB and MDD. Participants will receive either integrated TB and MDD treatment or standard TB treatment, depending on their assigned site. Baseline assessments will include depressive symptomatology (PHQ-9) and perceived social support (Oslo Social Support Scale, OSSS). Follow-up assessments will occur at two weeks, eight weeks, and 24 weeks, using the same instruments. TB-related outcomes - including treatment continuation, interruption, default, and mortality - will also be recorded. Stage 3 will use a qualitative approach to explore the experience and dimensions of stigma from the perspectives of service users, their family members, and their communities. Weighted prevalence of MDD will be estimated with 95% CIs. The proportion of participants reporting experiences of stigma will be described using frequency counts and percentages. Changes in depressive symptoms over time between the two treatment groups will be analyzed using mixed ANOVA. Qualitative data will be analyzed thematically.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...